图书馆订阅: Guest
肿瘤形成评论综述™

每年出版 4 

ISSN 打印: 0893-9675

ISSN 在线: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Drug Combinations with HDAC Inhibitors in Antitumor Therapy

卷 20, 册 1-2, 2015, pp. 83-117
DOI: 10.1615/CritRevOncog.2014012378
Get accessGet access

摘要

The treatment of tumor cells with HDAC inhibitors (HDACi) induces a range of effects including apoptosis, cell cycle arrest, differentiation and senescence, modulation of immune response, and altered angiogenesis. The single-agent activities of several HDACi have been tested in preclinical and clinical studies and are currently the subject of ongoing clinical trials. Although HDACi have been shown to be effective as a single agent against a defined subset of hematological tumors, less convincing results have been found in the treatment of solid tumors. Since current clinical trials of single-agent HDACi showed limited efficacy, in this review we focus on drug combinations including HDACi with conventional chemotherapeutic agents and novel targeted agents. Particular emphasis has been devoted to combinations effective in solid tumors and to combinations between HDACi and immunotherapies. An outline of novel combination strategies, including a new generation of more potent and specific HDACi (e.g., compounds with adamantine and noradamantane as scaffolds) as well as chemical hybrid molecules, has been provided. The paradoxical role of HDACs as tumor suppressors in developing tumors and as therapeutic targets in established neoplasms has also been considered.

对本文的引用
  1. Yazbeck Victor Y, Grant Steven, Romidepsin for the treatment of non-Hodgkin’s lymphoma, Expert Opinion on Investigational Drugs, 24, 7, 2015. Crossref

  2. Sarma Pranjal, Ramaiah M. Janaki, Pal Dhananjaya, Bhadra Utpal, Pal Bhadra Manika, A novel bisindole-PBD conjugate inhibits angiogenesis by regulating STAT3 and VEGF in breast cancer cells, Life Sciences, 151, 2016. Crossref

  3. Sauer M, Schuldner M, Hoffmann N, Cetintas A, Reiners K S, Shatnyeva O, Hallek M, Hansen H P, Gasser S, von Strandmann E P, CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells, Oncogene, 36, 7, 2017. Crossref

  4. Schäfer Claudia, Göder Anja, Beyer Mandy, Kiweler Nicole, Mahendrarajah Nisintha, Rauch Anke, Nikolova Teodora, Stojanovic Natasa, Wieczorek Martin, Reich Thomas R., Tomicic Maja T., Linnebacher Michael, Sonnemann Jürgen, Dietrich Sascha, Sellmer Andreas, Mahboobi Siavosh, Heinzel Thorsten, Schneider Günter, Krämer Oliver H., Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells, Cellular Signalling, 29, 2017. Crossref

  5. Apuri Susmitha, Sokol Lubomir, An overview of investigational Histone deacetylase inhibitors (HDACis) for the treatment of non-Hodgkin’s lymphoma, Expert Opinion on Investigational Drugs, 25, 6, 2016. Crossref

  6. Halsall John A., Turner Bryan M., Histone deacetylase inhibitors for cancer therapy: An evolutionarily ancient resistance response may explain their limited success, BioEssays, 38, 11, 2016. Crossref

  7. Beretta Giovanni Luca, Cassinelli Giuliana, Pennati Marzia, Zuco Valentina, Gatti Laura, Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents, European Journal of Medicinal Chemistry, 142, 2017. Crossref

  8. de Oliveira Felipe Leite, Carneiro Katia, Brito José Marques, Cabanel Mariana, Pereira Jonathas Xavier, Paiva Ligia de Almeida, Syn Wingkin, Henderson Neil C., El-Cheikh Marcia Cury, Fujiwara Ricardo Toshio, Galectin-3, histone deacetylases, and Hedgehog signaling: Possible convergent targets in schistosomiasis-induced liver fibrosis, PLOS Neglected Tropical Diseases, 11, 2, 2017. Crossref

  9. Li Ji-ping, Zhao Feng-li, Yuan Ye, Sun Ting-ting, Zhu Lei, Zhang Wen-you, Liu Mo-xiang, Studies on anti-angiogenesis of ginsenoside structure modification HRG in vitro, Biochemical and Biophysical Research Communications, 492, 3, 2017. Crossref

  10. Li Ran, Gan Ye-Hua, Inhibiting HDAC1 Enhances the Anti-Cancer Effects of Statins through Downregulation of GGTase-Iβ Expression, International Journal of Molecular Sciences, 18, 5, 2017. Crossref

  11. Moyal Lilach, Feldbaum Nataly, Goldfeiz Neta, Rephaeli Ada, Nudelman Abraham, Weitman Michal, Tarasenko Nataly, Gorovitz Batia, Maron Leah, Yehezkel Shiran, Amitay-Laish Iris, Lubin Ido, Hodak Emmilia, Wagner Bridget, The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin, PLOS ONE, 11, 1, 2016. Crossref

  12. Mahady Laura, Nadeem Muhammad, Malek-Ahmadi Michael, Chen Kewei, Perez Sylvia E., Mufson Elliott J., Frontal Cortex Epigenetic Dysregulation During the Progression of Alzheimer’s Disease, Journal of Alzheimer's Disease, 62, 1, 2018. Crossref

  13. Osipov Vasily N., Khachatryan Derenik S., Balaev Alexandr N., Biologically active quinazoline-based hydroxamic acids, Medicinal Chemistry Research, 29, 5, 2020. Crossref

  14. Zhang Bin, Zhang Qiting, Liu Zedong, Wang Ning, Jin Haixiao, Liu Feng, Zhang Cunlong, He Shan, Synthesis and Anticancer Research of N ‐(2‐aminophenyl)benzamide Acridine Derivatives as Dual Topoisomerase I and Isoform‐Selective HDAC Inhibitors , ChemistrySelect, 5, 27, 2020. Crossref

  15. Terranova-Barberio Manuela, Thomas Scott, Munster Pamela N, Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors, Immunotherapy, 8, 6, 2016. Crossref

  16. Cenklová Věra, Photodynamic therapy with TMPyP – Porphyrine induces mitotic catastrophe and microtubule disorganization in HeLa and G361 cells, a comprehensive view of the action of the photosensitizer, Journal of Photochemistry and Photobiology B: Biology, 173, 2017. Crossref

  17. Yang Qiwei, Falahati Ali, Khosh Azad, Mohammed Hanaa, Kang Wenjun, Corachán Ana, Bariani Maria Victoria, Boyer Thomas G., Al-Hendy Ayman, Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma, Cells, 11, 23, 2022. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain